P

resident Trump on Friday quietly signed into law a sweeping measure that will help ensure the Food and Drug Administration can continue to oversee drug and device approvals.

It’s a victory for the pharmaceutical industry, which, together with the FDA, fought to ensure the package would become law before existing agreements expire at the end of September. The industry will pay more than $1 billion toward the agency’s oversight efforts, per an agreement hammered out with lawmakers and the FDA. Both industry and the agency say the so-called user fees are critical to keeping the lights on at the FDA.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • So. Does this mean user fee biggest fee paid gets industries product pushed forward faster into commercial production?product

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.